Health Care

For GW Pharmaceuticals (NASDAQ: GWPH), the main growth strategy for the current fiscal year is to expand its product pipeline…

-- Arbutus Biopharma Corporation (NASDAQ:ABUS) reported a net loss of $164.9 million or $2.89 per share for fiscal 2019, compared…

-- BioCryst Pharmaceuticals (NASDAQ: BCRX) reported a loss of $0.02 per share for the fourth quarter of 2019 vs. expected…

-- AMAG Pharmaceuticals (NASDAQ: AMAG) reported a net loss of $199.9 million or $5.89 per share for the fourth quarter…

Tilray Inc  (NASDAQ: TLRY) Q4 2019 Earnings Conference Call Final Transcript Corporate Participants: Brendan Kennedy -- Chairman, President and Chief Executive Officer Mark…

-- Biotechnology company Amicus Therapeutics (NASDAQ: FOLD) reported a net loss of $356.4 million or $1.48 per share for fiscal…

-- Eagle Pharmaceuticals Inc. (NASDAQ: EGRX) reported its fourth-quarter 2019 adjusted earnings of $0.48 per share versus $0.46 per share…

Cara Therapeutics Inc  (NASDAQ: CARA) Q4 2019 Earnings Conference Call Final Transcript Corporate participants: Jack Hildick-Smith -- Investor Relations Derek Chalmers -- President, Director and…

Shares of SmileDirectClub Inc. (NASDAQ: SDC) plunged over 52% to $7.17 on Thursday, which is the lowest since the initial…

-- Sage Therapeutics (NASDAQ: SAGE) reported fourth quarter 2019 loss of $3.25 per share vs. expected loss per share of…